The validity of the test of individual equivalence ratios

Biometrika

Volumn 84, Issue 4, 1997, Pages 893-900

  Gene Hwang, J T ^a,b   Wang, Weizhen ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Crossover design; Symmetric distribution; Unimodal distribution

Indexed keywords

EID: 0000590222     PISSN: 00063444     EISSN: None     Source Type: Journal    
DOI: 10.1093/biomet/84.4.893     Document Type: Article

References (9)

1. ANDERSON, S. (1993). Measuring switchability and prescribability: When is average bioequivalence sufficient? J. Pharmacokin. Biopharm. 22, 551-64.
2. ANDERSON, S. HAUCK, W. W. (1990). Consideration of individual bioequivalence. J. Pharmacokin. Biopharm. 18, 259-73.
3. ANDERSON, T. W. (1955). The integral of a symmetric unimodal function over a symmetric convex set and some probability inequalities. Proc. Am. Math. Soc. 6, 170-6.
4. BIRNBAUM, Z. W. (1948). On random variables with comparable peakedness Ann. Math. Statist. 19, 76-81.
5. PDA (1992). PDA Guidance on Statistical Procedures for Bioequivalence Studies using a Standard TwoTreatment Crossover Design. Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
6. Liu, J. P. CHOW, S. C. (1997). A two one-sided tests procedure for assessment of individual bioequivalence. Statist. Med. To appear.
7. SCHALL, R. Luus, H. G. (1993). On population and individual bioequivalence. Statist. Med. 12, 1109-24.
8. WELLEK, S. (1989). Vorschläge zur Reformulierung der Statistischen Definition von Bioäquivalenz. In Medizinische Informatik und Statistik, Ed. G. Giani and R. Repges, pp. 95-9. Berlin, Heidelberg: SpringerVerlag.
9. WELLEK, S. (1993). Basing the analysis of comparative bioavailability trials on an individualized statistical definition of equivalence. Biom. J. 35, 47-55.